AGMB ▲ +4.3% - AgomAb Therapeutics NV $AGMB - Agomab to Present STENOVA Open-Label Extension Data of Ontunisertib at UEG Week 2026 and Host Scientific Symposium on Fibro-Inflammation 08-OCT-2026 04:05 PM ET